CD8A and neoplasm: Cytotoxic CD8+ T-lymphocytes (CTL) are considered the major defense mechanism against tumor cells, hence T-cell abundance is a decisive and crucial prognostic factor for immunotherapy and chemotherapy response, particularly at the early tumor initiation stage, where an increased activity of T cells has been reported (9).